DEX — Dextech Medical AB Income Statement
0.000.00%
Last trade - 00:00
- SEK94.28m
- SEK72.13m
- 39
- 13
- 45
- 21
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 2.26 | 0.596 | 0.635 | 3.12 | 8.71 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.36 | 7.71 | 6.08 | 5.27 | 4.94 |
Operating Profit | -8.36 | -7.71 | -6.08 | -5.27 | -4.94 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -8.36 | -7.71 | -6.08 | -5.27 | -4.59 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.36 | -7.71 | -6.08 | -5.27 | -4.59 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.36 | -7.71 | -6.08 | -5.27 | -4.59 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.36 | -7.71 | -6.08 | -5.27 | -4.59 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.558 | -0.509 | -0.401 | -0.285 | -0.248 |
Dividends per Share |